This Article Full Text Full Text (PDF) An author's correction has been published Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, M. Articles by Kao, G. D. Search for Related Content PubMed PubMed Citation Articles by Kim, M. Articles by Kao, G. D.

Caspase-Mediated Specific Cleavage of BubR1 Is a Determinant of Mitotic Progression

Mijin Kim, Katie Murphy, Fang Liu, Sharon E. Parker, Melissa L. Dowling, Wesley Baff, and Gary D. Kao^*

Departments of Radiation Oncology, Philadelphia Veterans Affairs Medical Center and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104

Received 22 December 2004/ Returned for modification 25 January 2005/ Accepted 26 July 2005

The fidelity of chromosomal duplication is monitored by cell cycle checkpoints operational during mitosis. One such cell cycle delay is invoked by microtubule-targeting agents such as nocodazole or paclitaxel (Taxol) and is mediated by mitotic checkpoint proteins that include BubR1. Relatively little is known about the regulation of expression and stability of BubR1 (or other checkpoint proteins) and how these factors dictate the durability of the cell cycle delay. We report here that treatment of HeLa cells with spindle-disrupting agents resulted in caspase activation and precipitated the cleavage of BubR1. This mechanism ultimately leads to reduced levels of full-length protein, which are accompanied by abrogation of the mitotic block; the checkpoint abrogation is substantially accelerated by inhibition of de novo protein synthesis. In contrast, inhibition of caspase activity blocked BubR1 degradation and prolonged mitosis. To confirm a direct link between caspase activity and BubR1 protein expression, we identified by site-directed mutagenesis the specific caspase cleavage sites cleaved after exposure to paclitaxel. Surprisingly, BubR1 has two sites of cleavage: primarily at Asp607/Asp610 and secondarily at Asp576/Asp579. BubR1 mutated at both locations (BubR1579610) was resistant to paclitaxel-induced degradation. Expression of BubR1579610 augmented the mitotic delay induced by spindle disruption in transfected cells as well as in clones engineered to inducibly express the mutant protein upon exposure to doxycycline and ultimately led to increased aneuploidy. Underscoring the importance of these caspase cleavage sites, both tetrapeptide motifs are identified in the amino acid sequences of human, mouse, chicken, and Xenopus BubR1. These results are potentially the first to link the control of the stability of a key mitotic checkpoint protein to caspase activation, a regulatory pathway that may be involved in killing defective cells and that has been evolutionarily conserved.

M.K. and K.M. contributed equally to this work.

This article has been cited by other articles:

• Hashimoto, T., Yamauchi, L., Hunter, T., Kikkawa, U., Kamada, S. (2008). Possible involvement of caspase-7 in cell cycle progression at mitosis.. GENES CELLS 13: 609-621 [Abstract] [Full Text]  
• Kim, M., Liao, J., Dowling, M. L., Voong, K. R., Parker, S. E., Wang, S., El-Deiry, W. S., Kao, G. D. (2008). TRAIL Inactivates the Mitotic Checkpoint and Potentiates Death Induced by Microtubule-Targeting Agents in Human Cancer Cells. Cancer Res. 68: 3440-3449 [Abstract] [Full Text]  
• Greene, L. M., Campiani, G., Lawler, M., Williams, D. C., Zisterer, D. M. (2008). BubR1 Is Required for a Sustained Mitotic Spindle Checkpoint Arrest in Human Cancer Cells Treated with Tubulin-Targeting Pyrrolo-1,5-Benzoxazepines. Mol. Pharmacol. 73: 419-430 [Abstract] [Full Text]  
• Faragher, A. J., Sun, X.-M., Butterworth, M., Harper, N., Mulheran, M., Ruchaud, S., Earnshaw, W. C., Cohen, G. M. (2007). Death Receptor-induced Apoptosis Reveals a Novel Interplay between the Chromosomal Passenger Complex and CENP-C during Interphase. Mol. Biol. Cell 18: 1337-1347 [Abstract] [Full Text]  
• Yamada, H. Y., Gorbsky, G. J. (2006). Spindle checkpoint function and cellular sensitivity to antimitotic drugs. Molecular Cancer Therapeutics 5: 2963-2969 [Full Text]